OJD  Vol.6 No.1 , February 2017
Persistent Depressive Disorder or Dysthymia: An Overview of Assessment and Treatment Approaches
Abstract: Persistent depressive disorder or dysthymia is a recurrent depressive disorder with no clearly demarcated episodes. Onset is insidious and can occur in adolescence or adulthood. Dysthymia frequently remains unrecognized and undiagnosed for years. Co-morbid major depression, anxiety, personality, somatoform and substance abuse disorders are common. Symptoms center on sad mood, pessimism and hopelessness. Sufferers experience significant functional impairment and are at risk of death by suicide. Those most at risk are female, unmarried, live in high income countries and have family histories of depression. Screening instruments include the Cornell Dysthymia Rating Scale (CDRS). Typical treatments are antidepressant medications and cognitive behavioral analysis system of psychotherapy (CBASP). This paper provides health professionals with an overview of assessment and treatment approaches in dysthymia.
Cite this paper: Melrose, S. (2017) Persistent Depressive Disorder or Dysthymia: An Overview of Assessment and Treatment Approaches. Open Journal of Depression, 6, 1-13. doi: 10.4236/ojd.2017.61001.

[1]   Abad, V. C., & Guilleminault, C. (2005). Sleep and Psychiatry. Dialogues in Clinical Neuroscience, 7, 291-303.

[2]   Akiskal, H. S. (1983). Dysthymic Disorder: Psychopathology of Double-Blind Long Term Extension of Several of These Proposed Chronic Depressive Subtypes. American Journal of Psychiatry, 140, 11-20.

[3]   Akiskal, H. S. (1996). Dysthymia as a Temperamental Variant of Affective Disorder. European Psychiatry, 11, 117s-22s.

[4]   American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington DC: Author.

[5]   American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders(4th ed., text rev.). Washington DC: Author.

[6]   American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington DC: Author.

[7]   Anisman, H., Ravindran, A., Griffiths, J., & Merali, Z. (1999). Interleukin-1 Beta Production in Dysthymia Before and After Pharmacotherapy. Biological Psychiatry, 46, 1649-1655.

[8]   Avrichir, B., & Elkis, H. (2002). Prevalence and Underrecognition of Dysthymia among Psychiatric Outpatients in Sao Paulo, Brazil. Journal of Affective Disorder, 69, 193-199.

[9]   Brunello, N., Akiskal, H., Boyer, P., Gessa, G., Howland, R., Langer, S. et al. (1995). Dysthymia: Clinical Picture, Extent of Overlap with Chronic Fatigue Syndrome, Neuropharmacological Considerations, and New Therapeutic Vistas. Journal of Affective Disorders, 52, 275-290.

[10]   Charlson, F., Ferrari, A., Flaxman, A., & Whiteford, H. (2013). 1. The Epidemiological Modelling of Dysthymia: Application for the Global Burden of Disease Study 2010. Journal of Affective Disorders, 151, 111-120.

[11]   Cristancho, M., Kocsis, J., & Thase, M. (2012). Dysthymia Disorder and Other Chronic Depressions. Focus the Journal of Lifelong Learning in Psychiatry, 10, 422-427.

[12]   Cohen, J. (1997). Assessment and Treatment of Dysthymia: The Development of the Cornell Dysthymia Rating Scale. European Psychiatry, 12, 190-193.

[13]   Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013). The Efficacy of Psychotherapy and Pharmacotherapy in Treating Depressive and Anxiety Disorders: A Meta-Analysis of Direct Comparisons. World Psychiatry, 12, 137-148.

[14]   Diaz, N., Horton, E., & Weiner, M. (2012). Dysthymia, Major Depression, and Double Depression among Individuals Receiving Substance Abuse Treatment. Health, 4, 1229-1237.

[15]   Dunner, D. (2005). Dysthymia and Double Depression. International Review of Psychiatry, 17, 3-8.

[16]   Feder, A. (n.d.) Chapter 3532: Somatization. General Medicine Clinics, Columbia Medical School Ambulatory Syllabus.

[17]   Furukawa, T., Schramm, E., Weitz, E. S., Salanti, G., Efthimiou, O., Michalak, J. et al. (2016). Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a Drug, or Their Combination: Differential Therapeutics for Persistent Depressive Disorder: A Study Protocol of an Individual Participant Data Network Meta-analysis. BMJ Open, 6, e011769.

[18]   Gwirtzman, H., Blehar, M., McCullough, J., Kocsis, J., & Prien, R., (1997). Standardized Assessment of Dysthymia. Report of a National Institute Mental Conference. Psychopharmacological Bulletin, 33, 3-11.

[19]   Gurege, O. (2011). Dysthymia in a Cross-cultural Perspective. Current Opinion in Psychiatry, 24, 67-71.

[20]   Halverson, J. (2015). Dysthymic Disorder: Background, Etiology, Epidemiology. Medscape.

[21]   Hellerstein, D., Batchelder, S., Lee, A., & Borisovskaya, M. (2002). Rating Dysthymia: An Assessment of the Construct and Content Validity of the Cornell Dysthymia Rating Scale. Journal of Affective Disorders, 71, 85-96.

[22]   Hellerstein, D., Agosti, V., Bosi, M., & Black, S. (2010). Impairment in Psychosocial Functioning Associated with Dysthymic Disorder in the NESARC Study. Journal of Affective Disorders, 127, 84-88.

[23]   Hellerstein, D. J., Skodol, A. E., Petkova, E., Xie, H., Markowitz, J. C., Yen, S., McGlashan, T. H. et al. (2010). The Impact of Comorbid Dysthymic Disorder on Outcome in Personality Disorders. Comprehensive Psychiatry, 51, 449-457.

[24]   Hellerstein, D. (2014). Dysthymic Disorder (Persistent Depressive Disorder). Encyclopedia of Psychopharmacology, Berlin: Springer.

[25]   Ishizaki, J., & Mimura, M. (2011). Dysthymia and Apathy: Diagnosis and Treatment. Depression Research and Treatment, 2011, Article ID: 893905.

[26]   Jobst, A., Brakemeier, E., Buchheim, A., Caspar, F., Cuijpers, P., Ebmeier, K. et al. (2016). European Psychiatric Association Guidance on Psychotherapy in Chronic Depression across Europe. European Psychiatry, 33, 18-36.

[27]   Joiner, T., Cook, J., Hersen, M., & Gordon, K. (2007). Double Depression in Older Adult Psychiatric Outpatients: Hopelessness as a Defining Feature. Journal of Affective Disorders, 101, 235-238.

[28]   Kannappan, R., & Bai, R. (2007). Cognitive Behaviour Therapy as an Adjunct to Drug Therapy in the Treatment of Dysthymic Disorder. Journal of the Indian Academy of Applied Psychology, 33, 195-200.

[29]   Keller, M., Hirschfeld, R., & Hanks, D. (1997) Double Depression: A Distinctive Subtype of Unipolar Depression. Journal of Affective Disorders, 45, 65-73.

[30]   Keller, M., McCullough, J., Klein, D., Arnow, B., Dunner, D., Gelenberg, A. et al. (2000). A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression. New England Journal of Medicine, 342, 1462-1470.

[31]   Kessler, R., Chiu, W., Demler, O., & Walters, E. (2005). Prevalence, Severity, and Comorbidity of Twelve-Month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627.

[32]   Klein, D., Schwartz, J., Rose, S., & Leader, J. (2000). Five-Year Course and Outcome of Dysthymic Disorder: A Prospective, Naturalistic Follow-Up Study. American Journal of Psychiatry, 157, 931-939.

[33]   Klein, D., Shankman, S., & Rose, S. (2006). Ten-Year Prospective Follow-Up Study of the Naturalistic Course of Dysthymic Disorder and Double Depression. American Journal of Psychiatry, 163, 872-880.

[34]   Kocsis, J., Gelenberg, A., Rothbaum, B., Klien, D., Trivedi, M., Manber, R. et al. (2009). Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression: The REVAMP Trial. Archives of General Psychiatry, 66, 1178-1188.

[35]   Kriston, L., Wolff, A., Westphal, A., Holzel, L., & Harter, M. (2014). Efficacy and Acceptability of Acute Treatments for Persistent Depressive Disorder: A Network Meta-Analysis. Depression and Anxiety, 31, 621-630.

[36]   Lam, R., Michalak, E., & Swinson, R. (2005). Assessment Scales in Depression, Mania and Anxiety. London: Taylor and Francis.

[37]   Levkovitz, Y., Tedeschini, E., & Papakostas, G. (2011). Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized Trials. Journal of Clinical Psychiatry, 72, 509-514.

[38]   Lizardi, H., & Klein, D. (2000). Parental Psychopathology and Reports of the Childhood Home Environment in Adults with Early-Onset Dysthymic Disorder. Journal of Nervous and Mental Disease, 188, 63-70.

[39]   Markkula, N., Suvisaari, J., Pirkola, S., Pena, S., Saarni, S., & Suvisaari, J. (2015). Prevalence and Correlates of Major Depressive Disorder and Dysthymia in an Eleven-Year Follow-Up—Results from the Finnish Health 2011 Survey. Journal of Affective Disorders, 173, 73-80.

[40]   Masi, G., Millepiedi, S., Mucci, M., Pascale, R. R., Perugi, G., & Akiskal, H. S. (2003). Phenomenology and Comorbidity of Dysthymic Disorder in 100 Consecutively Referred Children and Adolescents: Beyond DSM-IV. Canadian Journal of Psychiatry, 48, 99-105.

[41]   Mason, B., Kocsis, J., Leon, A., Thompson, S., Frances, A., Morgan, R. et al. (1993). Measurement of Severity and Treatment Response in Dysthymia. Psychiatric Annals, 23, 625-631.

[42]   Mayo Clinic (n.d.). Persistent Depressive Disorder (Dysthymia). Alternative Medicine.

[43]   McCullough, J. (1999). Treatment for Chronic Depression: Cognitive Behavioural Analysis System of Psychotherapy (CBASP). New York: Guilford Publications.

[44]   McCullough, J., Schramm, E., & Penberthy, K. (2015). CBASP: A Distinctive Treatment for Persistent Depressive Disorder. New York: Routledge.

[45]   Mead, G., Morley, W., Campbell, P., Greig, C., McMurdo, M., & Lawlor, D. (2010). Exercise for Depression. Cochrane Database of Systematic Reviews, CD004366.

[46]   Merikangas, K., He, J., Burstein, M., Swanson, S., Avenevoli, Cui, L. et al. (2010). Lifetime Prevalence of Mental Disorders in US Adolescents: Results from the National Comorbidity Study-Adolescent Supplement (NCS-A). Journal of the American Academy of Child Adolescent Psychiatry, 49, 980-989.

[47]   Negt, P., Brakemeier, E., Michalak, J., Winter, L., Bleich, S., & Kahl, K. (2016). The Treatment of Chronic Depression with Cognitive Behavioral Analysis System of Psychotherapy: A Systematic Review and Meta-Analysis of Randomized-Controlled Clinical Trials. Brain and Behavior, 6, e00486.

[48]   Niculescu, A., & Akiskal, H. (2001). Proposed Endophenotypes of Dysthymia: Evolutionary, Clinical and Pharmacogenomic Considerations. Molecular Psychiatry, 6, 363-366.

[49]   Pini, S., Cassano, G., Simonini, E., Savino, M., Russo, A., & Montgomery, S. (1997). Prevalence of Anxiety Disorders Comorbidity in Bipolar Depression, Unipolar Depression and Dysthymia. Journal of Affective Disorders, 42, 145-153.

[50]   Posner, J., Hellerstein, D., Gat, I., Mechling, A., Klahr, K., Wang, Z. et al. (2013). Antidepressants Normalize the Default Mode Network in Patients With Dysthymia. JAMA Psychiatry, 70, 373-371.

[51]   Randlov, C., Mehlsen, J., Thomsen, C., Hedman, C., von Fircks, H. et al. (2006). The Efficacy of St. John’s Wort in Patients with Minor Depressive Symptoms or Dysthymia—A Double-Blind Placebo-Controlled Study. Phytomedicine, 13, 215-221.

[52]   Ravidran, A., Chudzik, J., & Bialik R. (1994). Platelet Serotonin Measures in Primary Dysthymia. American Journal of Psychiatry, 151, 1369-1371.

[53]   Sandhu, R., Ghosh, S., & Dellenbaugh, T. (2016). Association between Dysthymic Disability and Disability, with Religiosity as Moderator. Activitas Nervosa Superior, 58, 13-19.

[54]   Sansone, R., & Sansone, L. (2009). Dysthymic Disorder: Forlorn and Overlooked. Psychiatry, 6, 46-51.

[55]   Sarris, J., O’Neil, A., Coulson, C. E., Schweitzer, I., & Berk, M. (2014). Lifestyle Medicine for Depression. BMC Psychiatry, 14, 107.

[56]   Scott, J., Baker, W., & Eccleston, D. (1988). The Newcastle Chronic Depression Study. Patient Characteristics and Factors Associated with Chronicity. British Journal of Psychiatry, 152, 28-33.

[57]   Shankman, S., & Klein, D. (2002). The Impact of Comorbid Anxiety Disorders on the Course of Dysthymic Disorder: A 5-Year Prospective Longitudinal Study. Journal of Affective Disorders, 70, 211-217.

[58]   Spanemberg, L., & Juruena, M. (2004). Dysthymia: Historical/Nosological Characteristics and Its Relationship with Major Depressive Disorder. Revista de Psiquiatria do Rio Grande do Sul, 26, 300-301.

[59]   Thase, M., Friedman, E., Biggs, M., Wisniewski, S., Trivedi, M., Luher, J. et al (2007). Cognitive Therapy versus Medication in Augmentation and Switch Strategies as Second-step Treatments: A STAR*D Report. American Journal of Psychiatry, 164, 739-752.

[60]   Tripodianakis, J., Markianos, M., Sarantidis, D., Spyropoulou, G., Taktikou, V., & Bistolaki, E. (1998). Platelet MAO Activity in Patients with Dysthymic Disorder. Psychiatry Research, 78, 173-178.

[61]   Uher, R. (2014). Persistent Depressive Disorder, Dysthymia, and Chronic Depression: Update on Diagnosis, Treatment. Psychiatric Times, 31, 46.

[62]   Weissman, M.M., & Klerman, G.L. (1977). The Chronic Depressive in the Community: Unrecognized and Poorly Treated. Comprehensive Psychiatry, 18, 523-532.

[63]   Williams, J., Crane, C., Barnhofer, T., van der Does, A., & Segal, Z. (2006). Recurrence of Suicidal Ideation across Depressive Episodes. Journal of Affective Disorders, 91, 189-194.

[64]   Wang, P., Lane, M., Olfson, M., Pincus, H., Wells, K., & Kessler, R. (2005). Twelve Month Use of Mental Health Services in the United States. Archives of General Psychiatry, 62, 629-640.

[65]   Wu, W., Wang, Z., Wei, Y., Zhang, G., Shi, S., Gao, J. et al. (2013) Clinical Features of Patients with Dysthymia in a Large Cohort of Han Chinese Women with Recurrent Major Depression. PLoS ONE, 8, e83490.

[66]   Young, A., Klap, R., Shoai, R., & Wells, K. (2008). Persistent Depression and Anxiety in the United States: Prevalence and Quality of Care. Psychiatric Services, 59, 1391-1398.